Government Affairs

Top Story

Reform Update: Medicaid programs crafting limits on Harvoni usage

Which Medicaid beneficiaries will have access to Gilead Sciences' newest high-cost hepatitis C treatment, Harvoni, and when they'll get that access, now depends on prior-authorization criteria being hammered out by various state agencies. Most will likely limit Harvoni use to patients dealing with......

Website, Data and Digital
Magazine: Print or Digital
Button to subscribe




Switch to the new Modern Healthcare Daily News app

For the best experience of on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.